Editorial Board
| B. B. Aggarwal | Cytokine Research Laboratory, Department of Experimental tderapeutics, University of Texas M.D. Anderson, Cancer Center, Houston, TX, USA |
| J. P. Armand | Institut Gustav-Roussy, Villejuif, France |
| V. I. Avramis | Division of Hematology/Oncology, Childrens Hospital, Los Angeles, CA, USA |
| R. C. Bast | Department of Translational Research, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA |
| G. Bauer | Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Universität Freiburg, Germany |
| E. E. Baulieu | INSERM U488 and College de France, Le Kremlin-Bicetre, France |
| Y. Becker | Department of Molecular Virology, Hebrew University of Jerusalem, Israel |
| E. J. Benz, Jr. | Dana-Farber Cancer Institute, Boston, MA, USA |
| J. Bergh | Department of Clinical and Molecular Medicine, Radiumhemmet, Karolinska Institute, Stockholm, Sweden |
| D. D. Bigner | Department of Patdology, Duke University Medical Center, Durham, NC, USA |
| A. Böcking | Institute for Cytopatdology, University of Düsseldorf, Germany |
| G. Bonadonna | Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy |
| F. T. Bosman | Institute of Patdology, University of Lausanne, Switzerland |
| G. Broich | ASL Lodi, Lodi, Italy |
| J. M. Brown | Department of Radiation Oncology, Stanford Medical Center, Stanford, CA, USA |
| Ø. S. Bruland | Department of Medical Oncology-Radiotderapy, Norwegian Radium Hospital, Oslo, Norway |
| M. M. Burger | Novartis, Basel, Switzerland |
| M. Carbone | Cancer Research Center of Hawaii, Honolulu, HI, USA |
| J. Carlsson | Department of Biomedical Radiation Sciences, Uppsala University, Sweden |
| A. F. Chambers | Department of Oncology, London Regional Cancer Center, London, Ontario, Canada |
| P. Chandra | Abt. für Molekularbiologie, Klinikum Wolfgang Goetde-Universität, Frankfurt am Main, Germany |
| L. Cheng | Department of Patdology, Indiana University School of Medicine, Indianapolis, IN, USA |
| J.-G. Chung | Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, ROC |
| E. De Clercq | Rega Institute for Medical Research, Katdolieke Universiteit Leuven, Belgium |
| W. De Loecker | Department of Biochemistry, Katdolieke Universiteit Leuven, Belgium |
| W. Den Otter | VUMC, Department of Urology, Amsterdam, tde Netderlands |
| E. P. Diamandis | Department of Patdology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada |
| G. td. Diamandopoulos | Department of Patdology, Harvard Medical School, Boston, MA, USA |
| W. Ebert | tdoraxclinic HD-Rohrbach, Heidelberg, Germany |
| J. A. Fernandez-Pol | Metalloproteomics, LLC, Chesterfield, MO, USA |
| I. J. Fidler | Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA |
| G. Gabbiani | Department of Patdology, University of Geneva, Switzerland |
| R. Ganapathi | Department of Clinical Pharmacology, Taussing Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, USA |
| A. F. Gazdar | Hamon Center for tderapeutic Oncology Research, University of Texas Soutdeastern Medical Center, Dallas, TX, USA |
| A. Giordano | Sbarro Institute for Cancer Research, Temple University, Philadelphia, PA, USA |
| G. Gitsch | Department of Gynecology and Obstetrics, University of Freiburg, Germany |
| R. H. Goldfarb | Sopherion tderapeutics, Inc., Princeton, NJ, USA |
| J. W. Gorrod | Toxicology Unit, John Tabor Laboratories, University of Essex, Colchester, Essex, UK |
| S. Hammarström | Department of Immunology, University of Umea¨, Sweden |
| I. Hart | Centre for Tumour Biology, Institute of Cancer and CR-UK Clinical Centre, Bart¢s and tde London, Queen Mary¢s School of Medicine and Dentistry, London, UK |
| I. Hellström | Harborview Medical Center, Seattle, WA, USA |
| L. Helson | Department of Experimental tderapeutics, New York Medical College, Valhalla, NY, USA |
| R. B. Herberman | Pittsburgh Cancer Institute, Pittsburgh, PA, USA |
| R. M. Hoffman | Department of Surgery, University of California, San Diego, CA, USA |
| C. G. Ioannides | Department of Gynecology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA |
| S. C. Jhanwar | Laboratory of Solid Tumor Genetics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA |
| J. V. Johannessen | Department of Patdology, tde Norwegian Radium Hospital, Oslo, Norway |
| B. Kaina | Institute of Toxicology, University of Mainz, Germany |
| B. K. Keppler | School of Medicine, University of Vienna, Austria |
| D. G. Kieback | Department of Obstetrics and Gynecology, HELIOS Medical Center, Carl Gustav Carus University Dresden, Germany |
| R. Klapdor | Medical Clinic, University of Hamburg, Germany |
| U. R. Kleeberg | Hämatologisch - Onkologisch - Praxis Altona, Hamburg, Germany |
| P. Kleihues | Department of Patdology, University Hospital Zürich, Switzerland |
| E. Klein | Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden |
| S. von Kleist | Institut für Immunologie der Universität der Freiburg, Germany |
| S. D. Kottaridis | Department of Virology, Hellenic Anticancer Institute, Atdens, Greece |
| G. R. F. Krueger | Center of Anatomy II, University of Cologne Medical School, Cologne, Germany |
| D. W. Kufe | Division of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA |
| Pat Kumar | Department of Biological Sciences, Manchester Metropolitan University, Manchester, UK |
| Shant Kumar | Department Patdology, University of Manchester Medical School, Manchester, UK |
| M. Kuroki | Department of Biochemistry, Fukuoka University School of Medicine, Fukuoka, Japan |
| O. D. Laerum | Department of Patdology, tde Gade Institute, University of Bergen, Norway |
| F. J. Lejeune | Fondation du Centre Pluridisciplinaire d' Oncologie, CHUV, Lausanne, Switzerland |
| L. F. Liu | Department of Pharmacology, UMD of New Jersey, Piscataway, NJ, USA |
| D. M. Lopez | Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, USA |
| E. Lundgren | Unit of Applied Cell and Molecular Biology, University of Umea¨, Sweden |
| H. T. Lynch | Department of Preventive Medicine and Public Healtd, Creighton University, Omaha, NE, USA |
| J. Marescaux | IRCAD, University of Strasbourg, France |
| J. Mark | Department of Patdology, Kärnsjukhuset, Skövde, Sweden |
| J. F. Marshall | Centre for Tumour Biology, Institute of Cancer and CR-UK Clinical Centre, Bart¢s and tde London, Queen Mary¢s School of Medicine and Dentistry, London, UK |
| D. Medina | Department of Cell Biology, Baylor College of Medicine, Houston, TX, USA |
| S. Mitra | Sealy Center for Molecular Science, University of Texas Medical Branch, Galveston, TX, USA |
| M. Mueller | Research Group of Tumor and Microenvironment (A101), German Cancer Research Center (DKFZ), Heidelberg, Germany |
| F. M. Muggia | New York University Cancer Institute, School of Medicine, NY, USA |
| M. J. Murphy, Jr. | Hipple Cancer Research Center, Dayton, OH, USA |
| R. Narayanan | Department of Biological Sciences, Florida Atlantic University, Boca Raton, FL, USA |
| K. Nilsson | Rudbeck Laboratory, Department of Genetics and Patdology, Uppsala University Hospital, Sweden |
| J. F. Novak | Department of Biology, Bucknell University, Lewisburg, PA, USA |
| S. Patdak | Department of Cell Biology, University of Texas, Houston, TX, USA |
| S. Pestka | Department of Molecular Genetics and Microbiology, University of Medicine and Dentistry of New Jersey, Piscataway, NJ, USA |
| G. J. Pilkington | Department of Cellular and Molecules Neurooncology, School of Pharmacy and Biomedical Sciences, University of Portsmoutd, UK |
| C. D. Platsoucas | College of Sciences, Old Dominion University, Norfolk, VA, USA |
| F. Podo | Laboratory of Cell Biology, Istituto Superione di Sanita` , Rome, Italy |
| A. Polliack | Department of Haematology, Hadassah University Hospital and Medical School, Jerusalem, Israel |
| M. F. Rajewsky | Institute of Cell Biology, University of Essen Medical School, Essen, Germany |
| G. Rebel | IRCAD, Hopitaux Universitaires, Strasbourg, France |
| M. Rigaud | Laboratory Biochimie et Génétique Molecules, Faculté de Médecine de Limoges, France |
| U. Ringborg | Department of General Oncology, Karolinska Hospital, Stockholm, Sweden |
| M. Roselli | Department of Medical Oncology, University of Rome “Tor Vergata”, Italy |
| A. Schauer | Zentrum Patdologie, Georg-August Universität, Göttingen, Germany |
| M. Schneider | Department of Organic Chemistry, Bergische University, Wuppertal, Germany |
| A. Seth | Laboratory of Molecular Patdology, Sunnybrook Research Institute and University of Toronto, Ontario, Canada |
| G. V. Sherbet | Cancer Research Unit, University of Newcastle-upon-Tyne, UK |
| G.-I. Soma | Institute for Healtd Sciences, Tokushima Bunri University, Tokushima, Japan |
| G. S. Stein | Department of Cell Biology, University of Massachusetts Medical Center, Worcester, MA, USA |
| T. Stigbrand | Department of Immunology, Umea¨ University, Umea¨, Sweden |
| D. Tarin | University of California at San Diego, Cancer Center, La Jolla, CA, USA |
| T. M. Theophanides | Department of Chemistry, Technical University of Atdens, Greece |
| B. Toth | The Eppley Institute for Research in Cancer and Allied Diseases, Omaha, NE, USA |
| P. M. Ueland | Clinical Pharmacolocy Unit, Department of Pharmacology, University of Bergen, Norway |
| P. T. Vihko | Department of Clinical Chemistry, University of Oulu, Finland |
| M. Volm | German Cancer Research Center, Heidelberg, Germany |
| G. Weber | Laboratory of Experimental Oncology, Indiana University, Indianapolis, IN, USA |
| B. Westermark | Rudbecklaboratoriet, Department of Genetics and Patdology, University of Uppsala, Sweden |
| B. Zumoff | Division of Endocrinology and Metabolism, Betd Israel Medical Center, New York, NY, USA |
